Sanjay K. Murthy is partner in the Intellectual Property practice in the Chicago office of Morgan, Lewis, & Bockius LLP. He has over 15-years of patent litigation experience representing leading life science and technology companies in US District Courts, before the Patent Trial and Appeal Board, and in Section 337 investigations in the US International Trade Commission (ITC).
Sanjay has successfully tried cases to juries on both US coasts on behalf of Fortune 500 companies, has first-chaired Markman hearings, and has argued numerous motions throughout the United States. In addition to his trial court experience, he has successful appellate experience and has handled matters before the US Courts of Appeals for the Federal and Ninth Circuits and the ITC. Sanjay has also successfully represented a number of clients in inter partes review proceedings. In 2017, Sanjay was named as one of the "Most Influential Minority Lawyers in Chicago" by Crain’s Chicago Business.
Sanjay has worked on a wide array of life science related technologies, such as medical devices (e.g., dialysis machines, drug infusion pumps, and stent grafts), pharmaceuticals, methods for manufacturing recombinant proteins (e.g., Factor VIII and alpha-1 antitrypsin), and stem cells. His representations include handling litigation and IPRs for Baxter Healthcare, Baxalta, Shire, and Praxair, among others. Most recently, he won an 11-patent ANDA case in the District of Delaware against Mallinckrodt.
Sanjay received an LLM in intellectual property law from The George Washington University Law School, a J.D. from California Western School of Law, where he was a dean’s full-tuition scholarship recipient, and a B.S., Biology with a minor in Chemistry from Loyola University.